Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.

about

Strengthening peptide-based drug activity with novel glyconanoparticle Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework

P2860

Q58691719-45C86B48-595A-4BF7-A03E-E22E07357D59 Q58788199-0E845F55-3FA4-45F3-8ED2-CC04F793F91B

P2860

Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.

Item

http://www.wikidata.org/entity/Q49788866

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Preclinical evaluation of the ...... tic for alcohol use disorders.

@en

Preclinical evaluation of the ...... tic for alcohol use disorders.

@nl

type

Item

label

Preclinical evaluation of the ...... tic for alcohol use disorders.

@en

Preclinical evaluation of the ...... tic for alcohol use disorders.

@nl

prefLabel

Preclinical evaluation of the ...... tic for alcohol use disorders.

@en

Preclinical evaluation of the ...... tic for alcohol use disorders.

@nl

P1476

Preclinical evaluation of the ...... tic for alcohol use disorders.

@en

P2093

D Gehlert

http://www.w3.org/2001/XMLSchema#string

E Augier

http://www.w3.org/2001/XMLSchema#string

E Barbier

http://www.w3.org/2001/XMLSchema#string

E Domi

http://www.w3.org/2001/XMLSchema#string

G Augier

http://www.w3.org/2001/XMLSchema#string

L Holm

http://www.w3.org/2001/XMLSchema#string

M Heilig

http://www.w3.org/2001/XMLSchema#string

R Barchiesi

http://www.w3.org/2001/XMLSchema#string

P2860

Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?

Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system

Dynorphin, stress, and depression

Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence

Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase

κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction

A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats

Affective cue-induced escalation of alcohol self-administration and increased 22-kHz ultrasonic vocalizations during alcohol withdrawal: role of kappa-opioid receptors.

The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors

The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat.

P2888

s41386-018-0015-y

P31

scholarly article

P356

10.1038/S41386-018-0015-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Annika Thorsell

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100838583

http://www.w3.org/2001/XMLSchema#string

P698

29463912

http://www.w3.org/2001/XMLSchema#string

P921

alcohol consumption

P932

6046052

http://www.w3.org/2001/XMLSchema#string

Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.

about

P2860

P2860

Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P407

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P407

P50

P577

P6179

P698

P921

P932